TB control: challenges and opportunities for India

Transactions of the Royal Society of Tropical Medicine and Hygiene
Madhukar PaiSrinath Satyanarayana

Abstract

India's TB control programme has treated over 19 million patients, but the incidence of TB continues to be high. TB is a major killer and drug-resistant TB is a growing threat. There are several likely reasons, including social conditions and co-morbidities that fuel the TB epidemic: under-investment by the government, weak programme implementation and management, suboptimal quality of care in the private sector, and insufficient advocacy around TB. Fortunately, India possesses the technical know-how, competence and resources to address these challenges. The End TB Strategy by WHO offers India an excellent blueprint to advance the agenda of TB control.

References

Feb 15, 2008·The New England Journal of Medicine·Prabhat JhaUNKNOWN RGI-CGHR Investigators
May 15, 2010·Science·Christopher Dye, Brian G Williams
May 17, 2011·PloS One·William A WellsMichael E Kimerling
Sep 10, 2011·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A D HarriesA Kapur
Mar 20, 2012·Thorax·Zarir F Udwadia
Feb 15, 2014·The European Respiratory Journal·Sandra V KikMadhukar Pai
Mar 29, 2014·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·C T SreeramareddyM Pai
Jul 1, 2014·Journal of Global Health·Arsalan CheemaKit Yee Chan
Nov 2, 2014·The European Respiratory Journal·Zhi Zhen QinJacob Creswell
Mar 25, 2015·PLoS Medicine·Madhukar Pai, Puneet Dewan
May 13, 2015·The Indian Journal of Medical Research·Madhukar Pai
Jun 10, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S SatyanarayanaM Pai
Aug 14, 2015·The Lancet Infectious Diseases·Jishnu DasMadhukar Pai
Mar 13, 2016·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A McDowell, M Pai

❮ Previous
Next ❯

Citations

Feb 18, 2016·Transactions of the Royal Society of Tropical Medicine and Hygiene·Joseph R FitchettElizabeth L Corbett
May 18, 2016·Lung India : Official Organ of Indian Chest Society·Amrita Daftary, Madhukar Pai
Feb 17, 2017·Journal of Epidemiology and Global Health·Madhukar Pai, Ziad A Memish
Jun 18, 2019·Infectious Diseases of Poverty·Daniel Chukwuemeka Ogbuabor, Obinna Emmanuel Onwujekwe
Feb 26, 2019·BMJ Global Health·Nesri PadayatchiMadhukar Pai
Apr 23, 2020·Journal of Family Medicine and Primary Care·Bijit BiswasNeeraj Agarwal
Jan 20, 2021·Nature Communications·Han FuNimalan Arinaminpathy
Feb 23, 2021·Health Care for Women International·Rajani SureshSaurabh Kumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.